Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

The Finviz API: Higher Limits, Clearer Data, and More Ways to Connect

Get Started Now

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

By Oculis Holding AG | June 09, 2025, 4:05 PM

Oculis Holding AG

ZUG, Switzerland, June 09, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the annual equity incentive awards granted to directors of the Company.

Attachments

Mentioned In This Article

Oculis Holding AG

Latest News

Oct-08	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Oct-07	Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day OCS GlobeNewswire
Oct-01	Oculis Joins the National Multiple Sclerosis Society's Campaign to End MS OCS -6.21% GlobeNewswire
Sep-30	Oculis Announces Resignation of Lionel Carnot from Board of Directors OCS GlobeNewswire
Sep-17	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Aug-24	First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis OCS GlobeNewswire
Aug-14	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Aug-10	Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis' Position as an Emerging Leading Neuro-Ophthalmology Company OCS GlobeNewswire
Aug-06	Oculis Reports Q2 2026 Financial Results and Provides Company Update OCS GlobeNewswire
Aug-05	Earnings To Watch: Oculis Holding AG (OCS) Reports Q2 2026 Result OCS GuruFocus.com
Aug-03	Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses OCS +5.13% GlobeNewswire
Jul-08	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Jul-02	Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference OCS GlobeNewswire
Jun-15	Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities OCS GlobeNewswire
Jun-11	Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026 OCS GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)